NCT02679053

Brief Summary

The aim of the study is to evaluate the effect of 6 weeks of aerobic endurance exercise as adon treatment for moderately to severely depressed inpatients. Endpoints are symptom severity, psychological variables, cognitive symptoms, sleep, hypothalamic-pituitary-adrenal axis (HPA-axis), Brain-derived neurotrophic factor (BDNF) and heartrate variability (HRV). Amendment 1 (Nov. 2016): additional evaluation of TNF-alpha at baseline, +2 weeks and post (+6weeks) in already existing blood samples.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Oct 2013

Typical duration for not_applicable depression

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

January 26, 2016

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 10, 2016

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

April 11, 2017

Status Verified

April 1, 2017

Enrollment Period

2.3 years

First QC Date

January 26, 2016

Last Update Submit

April 10, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Depressive Symptoms self rated

    Change in Score of Hamilton Depression Rating Scale (HDRS-17) from baseline until 6 months follow-up

    Baseline (pre), 1 week, 2 weeks, 6 weeks (post), 6 months (followup)

  • Depressive Symptoms physician rated

    Change in Score of Beck Depression Inventory (BDI) from baseline until 6 months follow-up

    Baseline (pre), 1 week, 2 weeks, 6 weeks (post), 6 months (follow-up)

Secondary Outcomes (15)

  • Cortisol awakening response (CAR)

    Baseline (pre), 2 weeks, 6 weeks (post), 6 months (follow-up)

  • Brain derived neurotrophic factor (Serum-BDNF)

    Baseline (pre), 2 weeks, 6 weeks (post), 6 months (followup)

  • Sleep (Subjective sleep Quality)

    Baseline (pre), 6 weeks (post), 6 months (followup)

  • Sleep (Polysomnography)

    Baseline (pre), 6 weeks (post)

  • Cognition

    Baseline (pre), 6 weeks (post), 6 months (followup)

  • +10 more secondary outcomes

Study Arms (2)

Exercise (IG)

EXPERIMENTAL

Aerobic exercise three times per week on indoor bicycles at 60 to 75% of maximal heartrate aiming at a weekly total of 17.5kcal/kg bodyweight for 6 consecutive weeks. The exercise will take place under supervision. At the end of every week physical fitness is evaluated by the queens step test.No other activities with moderate or high intensity are allowed throughout the intervention time.

Behavioral: Aerobic exercise

Control (CG)

PLACEBO COMPARATOR

Basic stretching and mobilisation program 3 times per week each for approx. 40 minutes, also under supervision for 6 consecutive weeks. At the end of every week physical fitness is evaluated by the queens step test.At the end of every week physical fitness is evaluated by the queens step test.No other activities with moderate or high intensity are allowed throughout the intervention time.

Behavioral: Placebo control

Interventions

Exercise (IG)
Placebo controlBEHAVIORAL
Control (CG)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Inpatient treatment on the Depression ward
  • International Classification of Diseases (ICD)-10: F32, F33 or F31
  • HDRS-17\>16 Points
  • written informed consent

You may not qualify if:

  • Any physical condition that prohibits endurance exercise
  • or more cardiovascular risk factors (hypertonia, family history, smoking, hypertriglyceridemia, diabetes)
  • pathological ECG
  • BMI \> 35 kg/m2
  • Pregnancy
  • acute suicidal Ideation
  • comorbid substance dependence (except nicotine)
  • Major comorbid psychiatric disorder
  • regular high intensity exercise prior to treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Psychiatric University Hospital

Basel, Basel, 4012, Switzerland

Location

Psychiatric Services Solothurn

Solothurn, Canton of Solothurn, 4503, Switzerland

Location

Related Publications (1)

  • Imboden C, Gerber M, Beck J, Eckert A, Puhse U, Holsboer-Trachsler E, Hatzinger M. Effects of Aerobic Exercise as Add-On Treatment for Inpatients With Moderate to Severe Depression on Depression Severity, Sleep, Cognition, Psychological Well-Being, and Biomarkers: Study Protocol, Description of Study Population, and Manipulation Check. Front Psychiatry. 2019 Apr 25;10:262. doi: 10.3389/fpsyt.2019.00262. eCollection 2019.

MeSH Terms

Conditions

Depression

Interventions

Exercise

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Christian Imboden, MD, Dr.

    Solothurner Spitäler AG

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 26, 2016

First Posted

February 10, 2016

Study Start

October 1, 2013

Primary Completion

February 1, 2016

Study Completion

March 1, 2017

Last Updated

April 11, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations